Tag: CBT > Controlled Substances Act

Cannabis Rescheduling

Will Judge’s Rescheduling Decision Be Influenced by Lone Opposed Party Witness DEA Did Not Discredit?

Some legal experts believe a pharmacologist’s testimony on currently accepted medical use could be the most damning for the Schedule III proposal.

August 28, 2026

Cannabis Rescheduling

Former Federal Prosecutor, Former IRS Lawyer Warn Cannabis Industry About Jumping on DEA Registration Bandwagon

The takeaway? Consult with experienced lawyers and tax professionals and consider the risks, as the landscape continues to shift.

May 18, 2026

Wyoming

Trump’s DOJ Allows Federal Prosecutors to Enforce Simple Cannabis Possession Crimes

The U.S. Attorney’s Office for the District of Wyoming says the Department of Justice “rescinded” previous guidance under Biden.

November 14, 2025

Cannabis Rescheduling

US House Subcommittee Advances Bill to Prevent Cannabis Rescheduling Under DOJ

The House appropriations bill would block the Department of Justice from using funds to reschedule or deschedule cannabis.

July 16, 2025

Cannabis Rescheduling

Increases in Number of States That Have Legalized Marijuana Obscures Fact That Cannabis Remains Federally Illegal in 2025

Even those who use medical marijuana in jurisdictions that have legalized medical marijuana are at risk of federal prosecution.

February 27, 2025

Top Stories

Cannabis Rescheduling Won’t Solve Industry Banking Problems, Legal Risks

Bank Secrecy Act obligations and federal anti-money laundering laws would still apply to cannabis under a Schedule III listing, legal expert says.

October 23, 2024

Top Stories

2 US House Democrats Nudge DEA to ‘Swiftly’ Reschedule Cannabis

Reps. Jerry Nadler and Frank Pallone Jr., both ranking members, wrote a letter to the attorney general and DEA administrator.

October 2, 2024

California

Treez Files Summary Judgement in Lawsuit Against Feds Over Cannabis-Related Visa Denial

The federal government claims Treez must show its software developer from India ‘does not aid and abet activities that violate the CSA.’

September 19, 2024

Cannabis Advertising

The Complex Impact of Rescheduling Cannabis on Advertising

The penalties for advertising Schedule I drugs don’t apply to Schedule III drugs, but cannabis businesses could be left in a precarious position.

September 17, 2024

Industry Headlines

MMJ BioPharma Suing DEA Over Cannabis Reform, Medical Research

The biopharmaceutical company filed a lawsuit, citing ‘unjustified’ delays in processing an application for medical research.

September 11, 2024

Banking Bill Cannabis Industry

Trump Signals Support for Federal Cannabis Rescheduling, Banking Reform

The GOP presidential candidate said he will focus on unlocking the ‘medical uses of marijuana to a Schedule 3 drug’ if elected in November.

September 9, 2024

2018 Farm Bill Status

4th Circuit Court Rules THC-O Meets Legal Definition of Hemp, Deviating From DEA

The federal court’s interpretation of the 2018 Farm Bill contradicts the Drug Enforcement Administration’s position that THC-O is illegal.

September 9, 2024